digital health tools glp-1 weight management Infographic: Understanding Loss Medications at a Glance Nutritional priorities to support GLP-1

ESPEN 60, 122134

New combination therapy of gliclazide and quercetin for protection against STZ-induced diabetic rats

The company's antibody-drug conjugate and bispecific antibody pipeline includes peptide-linker components, and its oncology focus positions it strongly in the Oncology Peptide Therapy segment (11.79% CAGR through 2031)

The term thermogenic isnt as complex as one might think the word means heat producing. As your body shaves off calories, it generates excess heat

Adults (above 18) to Lead End User Segment with 65% Market Share in 2025 Adults (above 18 ) are expected to remain the most lucrative segment, holding a market share of approximately 65% in 2025